Publications

IBS

Johansson, M-L., Nobaek, S., Berggren, A., Nyman, M., Björck, I., Ahrné, S., Jeppsson, B., and Molin, G. 1998. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content in faeces after ingestion of a rose-hip drink with fermented oats, Int. J. Fd. Microbiol. 42: 29-38.

Nobaek, S., Johansson, M.-L., Molin, G., Ahrné, S. and Jeppsson, B. 2000. Alteration of intestinal microflora is associated with reduction in abdominal blaoting and pain in patients with irritable bowel syndrome (IBS). Am J Gastroenterol 95: 1231-1238.

Niedzielin, K., Kordecki, H and Birkenfeld, B. 2001. A controlled double-blind, randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13:1-5

Additional gastro data

Johansson, M.-L., Molin; G., Jeppsson, B., Nobaek, S., Ahrné, S. and Bengmark, S. 1993. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol: 59: 15-20.

Young, R.J. and Vanderhoof, J.A. 1997. Probiotic therapy in children with short bowel syndrome and bacterial overgrowth. Poster presented at the Annual Meeting of the American Gastroenterological Association and American Association for the Study of Liver Diseases, May 11-14, Washington DC, USA.

Johansson, M.-L., Nobaek, S., Berggren, A., Jeppsson, B., Ahrné, S., Nyman, M., Björck, I. and Molin, G. 1998. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. Int J Food Microbiol: 42: 29-38.

Kingamkono, R., Sjögren, E. and Svanberg, U. 1999. Enteropathogenic bacteria in faecal swabs of young children fed on lactic-acid fermented cereal gruels. Epidemiol Infect: 122: 23-32

Chlebcewicz-Szuba, W., Birkenfeld, B., Piusinska and K., Rudnicki, J. 2001. Administration of Lactobacillus plantarum 299v in children with accute diarrhoea and during prolonged antibiotic treatment. Preliminary report.

Berggren A., Söderberg L., Önning G., Johansson Hagslätt M-L. and Axelsson I. 2003. Intestinal Function, Microflora and Nutrient Intake of Children after Administration of a Fermented Oat Product Containing Lactobacillus plantarum DSM 9843 (299v). Microb Ecol Health Dis: 15:160-168.

Wullt, M., Johansson Hagslätt, M.-L. & Odenholt, I. 2003. Lactobacillus plantarum 299v for the treatment of recurrent clostridium difficile-associated diarrhoea: A double-blind, placebo-controlled trial. Scand J Infect Dis: 35: 365-367

Klarin B, Johansson ML, Molin G, Larsson A, Jeppsson B. 2005 Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care. Jun; 9(3):R285-93.

Wullt M, Johansson Hagslatt ML, Odenholt I, Berggren A. 2007. Lactobacillus plantarum 299v Enhances the Concentrations of Fecal Short-Chain Fatty Acids in Patients with Recurrent Clostridium difficile-Associated Diarrhea. Dig Dis Sci. Apr 10.

Immunology

Cunningham-Rundles, S., Ahrné, S., Bengmark, S., Johann-Liang, R., Marshall, F., Metakis, L., Califano, C., Dunn, A-M., Grassey, C., Hinds, G. and Cervia, J. 2000. Probiotics and immune response. Am J Gastroenterol: 95: S22-S25.

Rask, C., Adlerberth, I., Berggren, A., and Wold, A., 2005. Differential effects on the innate and acquired cellular immunesystem by intake of different lactobacilli in human volunteers. Poster presentyed at EUPROBIO, October 2005, Krakow.

Cardiovascular Health/Metabolic

Bukowska, H., Piezul-Mróz, J., Jastrzebska, M., Chelstowski, K. And Naruszewicz, M. 1998. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 137: 437-438.

Naruszewicz, M., Johansson, M-L., Zapolska-Downar, D. and Bukowska, H. 2002. Effect of Lactobacillus plantarum 299v on cardiovascular risk factors in smokers. Am J Clin Nutr: 76: 1249-55.

Anti-inflammatory

Bukowska, H., Piezul-Mróz, J., Jastrzebska, M., Chelstowski, K. And Naruszewicz, M. 1998. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 137: 437-438.

Naruszewicz, M., Johansson, M-L., Zapolska-Downar, D. and Bukowska, H. 2002. Effect of Lactobacillus plantarum 299v on cardiovascular risk factors in smokers. Am J Clin Nutr : 76: 1249-55.

McNaught, C , E., Woodcock, N. P., Anderson, A, D. G. and MacFie, J., 2005. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr: 24, 211–219.

Active/Recovery/Nutrition

Önning, G, Berggren, A, Drevelius, M., Jeppsson, B., Lindberg, A-M and Johansson Hagslätt, M-L. 2003. Influence of a drink containing different antioxidants and Lactobacillus plantarum 299v on plasma total antioxidant capacity, selenium status and faecal microbial flora. Int J Food Sci Nutr, Vol.54, No.4:281-289

Sandberg A-S. 2006, Uptake of iron in an in-vitro model. (Probi AB, Internal report)

Bering S, Suchdev S, Sjoltov L, Berggren A, Tetens I, Bukhave K. 2006 A lactic acid-fermented oat gruel increases non-haem iron absorption from a phytate-rich meal in healthy women of childbearing age. Br J Nutr. Jul;96(1):80-5

Hulthén L. and Hoppe M 2007. Iron absorption in an iron supplemented fruit drink containing lactobacilli (Probi AB, Internal report)

Other

Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus
plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated
patients: a randomised controlled open pilot study. Crit Care. 2008;12(6):R136.

Contact

Ph.D, Research Manager
Niklas Larsson, telephone +46 46 286 89 21, mobile +46 761 18 26 99, e-mail: niklas.larsson@probi.se